A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503335-18-00

Acronym

ELVN-001-101

Enrollment

106

Registered

2024-05-17

Start date

2022-07-29

Completion date

Unknown

Last updated

2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic myeloid leukemia

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026